98%
921
2 minutes
20
HIV/AIDS is a public health problem that is transmitted through risky sexual behavior. The literature suggests that the perception of HIV risk is a motivator for the prevention of risky sexual behaviors. There is no culturally adapted scale to assess HIV risk perception in the Hispanic-American population. The aim of this research was to develop a scale to assess HIV risk perception in Hispanic-American young adults. A cross-sectional instrumental design was used, with a sample of students from the Chilean city with the highest HIV rates. Participants (n = 524) were between 18 and 33 years old, of whom 51% were women, 84.4% said they were heterosexual and 43.7% said they had not been tested for HIV/AIDS. The final scale has 9 items and 2 dimensions: (1) perceived risk susceptibility and (2) perceived risk severity. The results showed that the identified structure provided adequate levels of reliability (ω > .8) and presented evidence of validity, based on the internal structure of the test (i.e., using ESEM) and on the relationship with other variables (i.e., the sexual risk behaviors scale). In addition, the results showed strong invariance between the scores for men and women. It is concluded that the HIV risk perception scale has adequate psychometric properties to assess HIV risk perception in equivalent samples.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173927 | PMC |
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0231558 | PLOS |
J Travel Med
September 2025
Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Background: Although there is a rising trend in both dengue cases and immunocompromised conditions, there is limited research on how common severe dengue is in immunocompromised individuals. This data is key for those advising the ever-increasing numbers of immunocompromised travellers.
Methods: We conducted a systematic review and meta-analysis of studies reporting dengue frequency or outcomes in immunocompromised populations.
Indian J Med Microbiol
September 2025
Department of Clinical Microbiology, Christian Medical College, Vellore,632004, Tamil Nadu. Electronic address:
Lomentospora prolificans (formerly Scedosporium prolificans) is an emerging fungal pathogen, affecting both immunocompromised and immunocompetent individuals. Treatment is difficult due to intrinsic resistance against multiple anti-fungal agents. We describe five patients with L.
View Article and Find Full Text PDFJ Stroke Cerebrovasc Dis
September 2025
Department of Internal Medicine, University Teaching Hospital, Lusaka, Zambia; Department of Internal Medicine, University of Zambia School of Medicine, Lusaka, Zambia; Department of Neurology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
Background: Premature atherosclerosis has been observed among people with HIV (PWH) with high risk of cerebrovascular disease. The aim of this study was to evaluate premature atherosclerosis in young PWH with and without ischemic stroke.
Methods: We conducted a prospective case-control study at the University Teaching Hospital in Lusaka, Zambia between March 2022 and October 2024, comparing young PWH with non-cardioembolic ischemic stroke (cases) with PWH without a history of stroke (controls) matched (1:2) for age, sex and race.
Lancet HIV
September 2025
Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA; Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, WA, USA. Electronic address:
Background: Past cohort studies have examined mortality among children and young adolescents (aged 0-14 years) who have received antiretroviral therapy (ART), but no systematic reviews have been undertaken to synthesise these findings. Our study aims to provide the most comprehensive global estimates of paediatric mortality among children and adolescents receiving ART.
Methods: For this systematic review and meta-regression analysis, we searched PubMed and Embase from Jan 1, 1990 to July 31, 2024 for studies reporting mortality among children and young adolescents living with HIV who were on ART.